CareOregon – Notice of Data Event 
Kraig Biocraft Laboratories Adds European Union to Ever-growing Portfolio of Spider Silk Patents
ANN ARBOR, Mich., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”),...
Health Canada approval of low-dose colchicine for cardiovascular disease based on the COLCOT study
MYINFLA™ 0.5 mg has been approved by Health Canada for the reduction of cardiovascular risk in patients with coronary diseaseMONTREAL,...
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 NEW YORK,...
Sedation Dentistry West Lake Hills TX Launched For Patients With Anxiety Or Fear
Westlake Hills Dental Arts (+1-512-328-0155) based in West Lake Hills, TX, has updated its range of sedation dentistry services to...
Initial Dan-NICAD II results presented today at ESC
Press releaseMalmö, Sweden, August 27, 2021 Initial Dan-NICAD II results presented today at ESC Study confirms excellent rule-out capacity...
Genmab to Present at Morgan Stanley 19th Annual Global Healthcare Conference
Media ReleaseCopenhagen, Denmark, 27 August, 2021 Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D....
Aino Health AB (publ): Aino Health signs membership in CSR Sweden
Stockholm August 27, 2021 Aino Health signs membership in the sustainability platform CSR Sweden. Together, they hope to contribute to...
Immunicum Announces Participation in Multiple Upcoming Industry and Investor Events in September and October
Press Release 27 August 2021 Immunicum Announces Participation in Multiple Upcoming Industry and Investor Events in September and October Immunicum...
Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody
SHANGHAI, China, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated...
CytoDyn Appoints Seenu Srinivasan, Ph.D. as Executive Director of CMC Regulatory Affairs
Dr. Srinivasan provides 30 years of broad regulatory and drug development experience including a career serving as Director of CMC...
Chalice Brands Ltd. Continues Sequential Revenue Growth
Reports Second Quarter 2021 Revenues of $6.9 Million and Third Consecutive Quarter of Positive Adjusted EBITDA(1) PORTLAND, Ore., Aug. 26,...
Imagin Medical Secures New $3 Million Convertible Note Financing
Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of...
Cellectis Announces Participation in Five Investor Conferences
NEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing...
Streamline Health® To Report Second Quarter 2021 Financial Performance and Provide Corporate Update
ATLANTA, GA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program...
Premier Health Reports Strong 3ʳᵈ Quarter Results
MONTRÉAL, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech...
Sight Sciences to Participate in the Morgan Stanley Global Healthcare Conference
MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused...
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155...
Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
Kathleen Sebelius Chair of Humacyte's Board of Directors Dr. Laura Niklason Founder, President & CEO of Humacyte Rajiv Shukla CEO...
Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 Outlook
Reports second quarter 2021 commercial revenue of $5.7 million, representing 135% year-over-year growth Issues full-year 2021 outlook for commercial revenue...
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
Innovent will provide proprietary antibodies for selected tumor targets and Bolt will provide its proprietary Boltbody™ technology to create new...